Cases 1 - 10 of 28
Novo Nordisk A/S et al v. Jack&Jill Health, Inc.
as 1:2024cv01360
Defendant:
Jack&Jill Health, Inc.
Plaintiff:
Novo Nordisk A/S and Novo Nordisk Inc.
Cause Of Action: 15 U.S.C. § 1051 Trademark Infringement
Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2024cv01014
Plaintiff:
Novo Nordisk A/S and Novo Nordisk Inc.
Defendant:
Sun Pharmaceutical Industries, Inc. and Sun Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv01013
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00775
Counter-Defendant:
Novo Nordisk Inc. and Novo Nordisk A/S
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Mylan Pharmaceuticals Inc.
Counter-Claimant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00050
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2023cv01459
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Meitheal Pharmaceuticals, Inc. et al
as 1:2023cv01195
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Meitheal Pharmaceuticals, Inc. and Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Orbicular Pharmaceutical Technologies Pvt. Ltd.
as 1:2023cv00179
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Orbicular Pharmaceutical Technologies Pvt. Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Viatris Inc. et al
as 1:2023cv00101
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
